Vaccines & Autism

The capacity of a vaccine to have the desired positive effects on immunized individuals within a certain group under optimal use circumstances is known as vaccine effectiveness. Weighing the potential risk of an adverse event following immunization (AEFI) with a vaccine against its potential benefits—such as promoting health and well-being and protecting against sickness and its physical, psychological, and economical consequences—is necessary. The likelihood that an unfavorable or undesirable event would occur and the degree of the harm that will ensue to the health of vaccinated persons within a specific community after receiving a vaccine under optimal usage settings are known as vaccine-associated risk.

 

    Related Conference of Vaccines & Autism

    May 30-31, 2024

    World congress on Immunology and Virology Diseases

    Vienna, Austria
    August 01-02, 2024

    44th Global Summit and Expo on Vaccines & Immunology

    Montreal, Canada
    September 09-10, 2024

    4th International Conference on Vaccine Research

    Madrid, Spain
    September 09-10, 2024

    7th International Conference on Vaccines and Immunology

    Madrid, Spain
    November 28-29, 2024

    6th World Congress on Vaccine and Immunology

    Paris, France

    Vaccines & Autism Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in